-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Buy on Globus Medical, Raises Price Target to $105

Benzinga·11/18/2025 13:36:00
Listen to the news
Truist Securities analyst Richard Newitter reiterates Globus Medical (NYSE:GMED) with a Buy and raises the price target from $93 to $105.